News

Spruce Biosciences which is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders asserted the launch of its Congenital Adrenal Hyperplasia…
Read More...

OrthoSpin which is a portfolio company of the Trendlines Group declared that it had successfully completed a first-in-human case for smart, robotic external fixation system assuring…
Read More...

Median Technologies, the industry-leading Imaging Phenomics Company and CMIC HOLDINGS Co., Ltd. (CMIC), a leading Contract Research Organization (CRO) with services for development,…
Read More...

The Medicines Company  declared that its Board of Directors has appointed Dr. Sarah Schlesinger as a new, independent Director of the Company, effective immediately. Dr. Schlesinger…
Read More...

Invicro, a Konica Minolta company asserted that Mr. Edward Hogan, M.S has been appointed as Senior Vice President of Clinical Operations. Mr. Hogan brings extensive medical imaging and…
Read More...

ENYO Pharma SA declared that it is strengthening its leadership team with the appointment of a VP Non-Clinical Development & Product Profiling. ENYO Pharma also confirms that its…
Read More...

ALung Technologies asserted that it has initiated enrolling patient in its VENT-AVOID Trial of the Hemolung RAS. The Minneapolis Heart Institute Foundation recently enrolled the first…
Read More...

Johnson and Johnson Medical Companies asserted that Acclarent,Inc which is a leader in developing minimally-invasive Ear, Nose and Throat technologies has sought clearance from the U.S…
Read More...

Houston-based company specializing in dental sleep medicine and sleep apnea treatment, The Center for Craniofacial & Dental Sleep Medicine (CFDSM) assured that it has sought FDA…
Read More...

Sierra Oncology which is a clinical stage drug development company aiming to further the DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer, today…
Read More...

Celltex Therapeutics Corporation asserted its authorization to conduct an investigational protocol which is a Phase II B Wellness Protocol Clinical Study on Rheumatoid Arthritis and…
Read More...

Aldeyra Therapeutics enters into a collaborative research agreement with Janssen Research and Development, LLC which is ideally one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

Aridis Pharmaceuticals applying proprietary technologies to curate novel anti-infectives and immunotherapies for infectious diseases proclaimed that it has created a Joint Venture with …
Read More...

Beacon Discovery asserted the formulation of a multi-year drug discovery collaboration with Takeda Pharmaceutical Company aiming to develop G-protein coupled receptors paving way for…
Read More...

Amgen asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending a label variation for Neulasta…
Read More...

Abbott and Surmodics proclaimed having forayed into an agreement wherein Abbott will possess exclusive commercialization rights for Surmodic's Surveil drug-coated balloon to treat the…
Read More...

Longeveron asserted that its revolutionary Clinical Trial initiated to treat infants with Hypoplastic Left Heart Syndrome as the first patient received the treatment using the company's…
Read More...

Medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, Access Vascular asserted that the Company has sought …
Read More...

Eli Lilly and Company proclaimed that the USFood and Drug Administration has sanctioned Verzenio (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based…
Read More...

PharmaCyte Biotech aiming to develop targeted cellular therapies for Cancer and diabetes using its signature  live-cell encapsulation technology, Cell-in-a-Box, announced that its…
Read More...